Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure-Reference-Cited by-同舟云学术

Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure

Published:2024-01 Issue: Volume:210 Page:249-255
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Kalantari Sara,Oren Daniel^ORCID,Medvedofsky Diego,Narang Akhil,Imamura Teruhiko,Tayazime Sarah,Kim Gene H.,Raikhelkar Jayant,Sayer Gabriel,Lang Roberto M.,Uriel Nir

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. The mechanism of action of LCZ696;Menendez;Card Fail Rev,2016

2. The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan;Jhund;Heart,2016

3. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

4. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

5. Angiotensin-neprilysin inhibition in acute decompensated heart failure;Velazquez;N Engl J Med,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse Remodeling in Heart Failure With Reduced Ejection Fraction Induced by Sacubitril-Valsartan: 3-Dimensional Echocardiography May Be a Useful Tool for the Future;The American Journal of Cardiology;2024-01

2. Corrigendum to ‘Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure’ [American Journal of Cardiology 210 (2024) 249-255];The American Journal of Cardiology;2023-12